9,10-dimethyl-1,2-benzanthracene has been researched along with ps1145 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chaturvedi, U; Gandham, RK; Gupta, SK; Kumar, R; Rajmani, RS; Sahoo, AP; Saxena, S; Singh, PK; Tiwari, AK | 1 |
1 other study(ies) available for 9,10-dimethyl-1,2-benzanthracene and ps1145
Article | Year |
---|---|
Administration of IκB-kinase inhibitor PS1145 enhances apoptosis in DMBA-induced tumor in male Wistar rats.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Apoptosis; Cell Line, Tumor; Heterocyclic Compounds, 3-Ring; I-kappa B Kinase; Male; Neoplasms, Experimental; NF-kappa B; Phosphorylation; Pyridines; Random Allocation; Rats; Rats, Wistar; Signal Transduction; Vascular Endothelial Growth Factor A | 2015 |